Author

Abigail O'Connell

October 28, 2024

Increasing Access to Treatments: Synapticure’s Role in the Clene EAP

Learn how Synapticure is advancing access to treatments through an NIH-funded Expanded Access Program and what it means long term.
October 28, 2024

Early Successes in Remote Research: Enabling Enrollment in Clinical Trials

Synapticure's virtual platform ensures equitable access to investigational ALS therapies, overcoming geographical and socioeconomic barriers

It is time to leave behind the era of

“I’m sorry but we can’t help you.”

Book your visit
Patients & Families
How It WorksFrequently Asked Questions
For Partners
ProvidersPayersGUIDEResearch
Our Services
Alzheimer's DiseaseFrontotemporal DementiaALS & PLSParkinson's DiseaseHuntington's DiseaseMental Health Care
About us
Leadership TeamOur CliniciansCareersCollaborators & SupportersContact
Resources
Our BlogPress Releases
Legal
Privacy PolicyTerms of ServiceNotice of Privacy PracticesConsumer Health Data Privacy PolicyTelehealth Informed ConsentFCOINondiscrimination Notice

This office appreciates the diversity of human beings and does not discriminate based on race, age, religion, ability,  marital status, sexual orientation, sex or gender identity.

Synapticure logo whitePh: +1 708-630-1534
Fax: +1 888-517-8619

2045 W Grand Ave Ste B Chicago, IL 60612

AICPA SOC 2 logo
© Copyright Synapticure. All rights reserved.